Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2025-12-25 @ 4:12 PM
Study NCT ID:
NCT01891357
Status:
TERMINATED
Last Update Posted:
2019-09-17
First Post:
2013-05-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
Sponsor:
West German Study Group